Analysis of telomere length in mantle cell lymphoma

European Journal of Haematology

Volumn 83, Issue 5, 2009, Pages 433-438

  Cottliar, Alejandra S H ^a   Panero, Julieta ^a   Pedrazzini, Estela ^a   Noriega, Maria Fernanda ^a   Narbaitz, Marina ^a   Rodríguez, Andrea ^a   Slavutsky, Irma ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

Mantle cell lymphoma; Telomere length; Terminal restriction fragments

Indexed keywords

CD19 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CCND 1 GENE; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; RESTRICTION FRAGMENT; SOUTHERN BLOTTING; TELOMERE; TELOMERE LENGTH; TERMINAL RESTRICTION FRAGMENT;

EID: 70349958242     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01313.x     Document Type: Article

References (32)

1. Harris NL. Mature B-cell neoplasms. In : Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology & Genetics of Tumors of Haematopietic and Lymphoid Tissue. World Health Organization (WHO) Classification of Tumours. Lyon : IARC Press, 2001 : 118 187.
2. H genes and the frequency of somatic mutations. Blood 2003 101 : 4042 4046.
3. H mutational status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003 102 : 3003 3009.
4. Blackburn EH. Structure and function of telomeres. Nature 1991 350 : 569 572.
5. Blackburn EH. Telomere states and cell fates. Nature 2000 408 : 53 6.
6. Chen LY, Liu D, Songyang Z. Telomere maintenance through spatial control of telomeric proteins. Mol Cell Biol 2007 27 : 5898 5909.
7. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990 345 : 458 460.
8. Counter CM, Avilion AA, Lefeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992 11 : 1921 1929.
9. Ramakrishnan S, Sharma HW, Farris AD, et al. Characterization of human telomerase complex. Proc Natl Acad Sci USA 1997 94 : 10075 10079.
10. Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001 10 : 677 685.
11. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994 266 : 2011 2015.
12. Weng N-P, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 1997 94 : 10827 10832.
13. Norrback K-F, Hultdin M, Dahlenborg K, Osterman P, Carlsson R, Roos G. Telomerase regulation and telomere dynamics in germinal centers. Eur J Haematol 2001 67 : 309 317.
14. Hahn WC. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 2003 21 : 2034 2043.
15. Gisselsson D, Jonson T, Petersen A, et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci USA 2001 98 : 12683 12688.
16. Remes K, Norrback K-F, Rosenquist R, Mehle C, Lindh J, Roos G. Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 2000 82 : 601 607.
17. Cottliar A, Pedrazzini E, Corrado C, Engelberger MI, Narbaitz M, Slavutsky I. Telomere shortening in patients with plasma cell disorders. Eur J Haematol 2003 71 : 334 340.
18. Ladetto M, Compagno M, Ricca I, et al. Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood 2004 103 : 4644 4649.
19. Cottliar ASH, Noriega MF, Narbaitz M, Rodríguez A, Slavutsky I. Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas. Cancer Genet Cytogenet 2006 171 : 1 8.
20. Walsh SH, Grabowski P, Berglund M, et al. Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas. Eur J Haematol 2007 78 : 283 289.
21. Pott C, Tiemann M, Linke B, et al. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Leukemia 1998 12 : 1630 1637.
22. Pedrazzini E, Cerretini R, Noriega MF, et al. Inversions of chromosomes 2 and 6 in mantle cell lymphoma. Cytogenetic, FISH and molecular studies. Cancer Genet Cytogenet 2006 167 : 164 167.
23. Vaziri H, Schächter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993 52 : 661 667.
24. Smogorzewska A, de Lange T. Regulation of telomerase by telomeric proteins. Ann Rev Biochem 2004 73 : 177 208.
25. Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol 2003 34 : 1030 1034.
26. Espinet B, Solé F, Pedro C, et al. Clonal proliferation of cyclin D1-positive mantle cell lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol 2005 36 : 1232 1237. (Pubitemid 41540401)
27. Lee JJ, Nam CE, Cho SH, Park KS, Chung IJ, Kim HJ. Telomere length shortening in non-Hodgkin′s lymphoma patients undergoing chemotherapy. Ann Hematol 2003 82 : 492 495.
28. Franco S, Ozkaynak MF, Sandoval C, et al. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia 2003 17 : 401 410.
29. Wu K-D, Orme LM, Shaughnessy J Jr., Jacobson J, Barlogie B, Moore MAS. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 2003 101 : 4982 4989.
30. Roos G, Kröber A, Grabowski P, et al. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 2008 111 : 2246 2252.
31. Rossi D, Lobetti Bodoni C, Genuardi E, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter′s syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009 23 : 1062 1072.
32. Phatak P, Burger AM. Telomerase and its potential for therapeutic intervention. Br J Pharmacol 2007 152 : 1003 1011.